RecruitingPhase 3NCT07794579A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesitySponsor: Eli Lilly and CompanyAustin, TX · Brownsville, TX · Dallas, TX · +77 more sites
RecruitingPhase 3NCT07564414A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightSponsor: Novo Nordisk A/SAmarillo, TX · Austin, TX · +96 more sites
Not yet recruitingPhase 3NCT07881432A Study of EloraTZP in Adult Participants With Obesity Without Type 2 DiabetesSponsor: Eli Lilly and CompanyBellaire, TX · Dallas, TX · +52 more sites